{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "path": "nfkb/seo2017.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1b, IL-6 and TNF-a are consequences of high Ab levels [30,31].",
      "key": "cb1914278958b553eefcca7aac36b1be",
      "line": 79,
      "relation": "increases",
      "source": 6,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1b, IL-6 and TNF-a are consequences of high Ab levels [30,31].",
      "key": "89bd3c524e11fce107f3d78991e14060",
      "line": 80,
      "relation": "increases",
      "source": 6,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1b, IL-6 and TNF-a are consequences of high Ab levels [30,31].",
      "key": "692c6b52250c7e392ab62f6d4aec91a6",
      "line": 81,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1b, IL-6 and TNF-a are consequences of high Ab levels [30,31].",
      "key": "96e5822abe8e88eaf55037095fd2b42c",
      "line": 82,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1b, IL-6 and TNF-a are consequences of high Ab levels [30,31].",
      "key": "9d5203fb362c75e3ef5b700d237ca5e2",
      "line": 83,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true,
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, Ab induced NF-kB activity in glial and neuronal cells. NF-kB is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "f248af3183e24b188c542139300b2b03",
      "line": 91,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 6,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true,
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, Ab induced NF-kB activity in glial and neuronal cells. NF-kB is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "5aa51479ecda71d2468dd5236f6e1fa6",
      "line": 92,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 51,
      "target": 73
    },
    {
      "annotations": {
        "CellLine": {
          "HepG2": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of NF-kB in TNF-a induced HepG2 cells [193].",
      "key": "92dbabb30c867a55c402fb1e84d1ccaa",
      "line": 448,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 107,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true,
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, Ab induced NF-kB activity in glial and neuronal cells. NF-kB is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "4f7fe36d1962748ea21720e4c7ddc173",
      "line": 92,
      "relation": "association",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "3674a7d60a2d11fb494cd6de55d468c0",
      "line": 108,
      "relation": "increases",
      "source": 73,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, Ab induced NF-kB activity in glial and neuronal cells. NF-kB is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "b42e94512ed3bf89595716467bdc7064",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 73,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Degeneration of neurons in the brain of AD patients is associated with the activation of NF-kB [7",
      "key": "9ca4961360c8d8641f7b85879aadbba2",
      "line": 115,
      "relation": "association",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "3826cf3639ecbb5fb195fb242a70b8c2",
      "line": 125,
      "relation": "regulates",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "ef5872ca10c4f8eeded195c147c3d17a",
      "line": 126,
      "relation": "regulates",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "4c72e59367144f8d22c870cc540ccdff",
      "line": 127,
      "relation": "regulates",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "fcc940895d5495007853d96453d05520",
      "line": 128,
      "relation": "regulates",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "1fdcdb0b9ee2d635f7565fb9675657f1",
      "line": 129,
      "relation": "association",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "e5c889dc16516b9a43533e4979eb9070",
      "line": 130,
      "relation": "association",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 125
    },
    {
      "key": "078e9aab87495fc560fd4240637a6294",
      "relation": "hasVariant",
      "source": 73,
      "target": 74
    },
    {
      "key": "cbc29242b6bedeeb329be47bb2e81b68",
      "relation": "partOf",
      "source": 73,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, Ab induced NF-kB activity in glial and neuronal cells. NF-kB is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "d0a2eee8f160b8c7f45a5e4da9370c36",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "356e0f0e5c5edfa177316773ad8ad338",
      "line": 103,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "624c133b68ffe34c5ffbc63e1a157645",
      "line": 104,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "4b2b527fccbca4504ddc54a0bb3eb3f4",
      "line": 105,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 11,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "1102ad0a796aec883affa84d76223dea",
      "line": 107,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 75,
      "subject": {
        "modifier": "Activity"
      },
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-kB and the expression of pro-inﬂammatory genes [41].",
      "key": "00e006173b16e97ad19fd197260d4827",
      "line": 106,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 73
    },
    {
      "key": "1bed415e6f92081e6134972098f3e122",
      "relation": "hasVariant",
      "source": 66,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Degeneration of neurons in the brain of AD patients is associated with the activation of NF-kB [7",
      "key": "1d771be9099b6b6e5a2587d25376a52d",
      "line": 115,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 111,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "e1441baaf6edf83060f7aaedcfdb5650",
      "line": 129,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 120,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "NF-kB activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-kB activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "26b2d3602e83af243a2bfc634d1426b9",
      "line": 130,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 125,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "a43946c3e1d93c18fc14d066232e2853",
      "line": 143,
      "relation": "decreases",
      "source": 18,
      "target": 51
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "3572ad9b6c549dddc8b9eaf989ff0c28",
      "line": 144,
      "relation": "decreases",
      "source": 18,
      "target": 97
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "10fc31536fd71001a89b719b5fc968dd",
      "line": 145,
      "relation": "decreases",
      "source": 18,
      "target": 89
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "b994a1fec3b4781d70d46f78a3c34821",
      "line": 146,
      "relation": "decreases",
      "source": 18,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "a1b9d3b83071aaf20a1a6eda3ca7a550",
      "line": 147,
      "relation": "decreases",
      "source": 18,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "dfb5ea62b93940090ba811ba4789996b",
      "line": 148,
      "relation": "decreases",
      "source": 18,
      "target": 85
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "0192caf4e464762e894d3b54ef1f4078",
      "line": 149,
      "relation": "decreases",
      "source": 18,
      "target": 87
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "a9deaa19873754c0118e8416ee4b264c",
      "line": 150,
      "relation": "decreases",
      "source": 18,
      "target": 88
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "cf19c52af5cabb2708ed10af5556b048",
      "line": 151,
      "relation": "decreases",
      "source": 18,
      "target": 80
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "54304151397920f032595d6179bc7387",
      "line": 152,
      "relation": "decreases",
      "source": 18,
      "target": 84
    },
    {
      "annotations": {
        "Cell": {
          "alveolar macrophage": true,
          "monocyte": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-a, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "0702b408b589e3b04aa8445cc2c3a902",
      "line": 153,
      "relation": "decreases",
      "source": 18,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-kB pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of IKB and the nuclear translocation of NF-kB p65 [106].",
      "key": "075d081580d172c22606c60de3bc5542",
      "line": 162,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-kB pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of IKB and the nuclear translocation of NF-kB p65 [106].",
      "key": "336203ab183e5ded958b683480d6477b",
      "line": 163,
      "relation": "decreases",
      "source": 18,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-kB pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of IKB and the nuclear translocation of NF-kB p65 [106].",
      "key": "7604dc7f24adc3b015df1b85d7aa6c90",
      "line": 164,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 18,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-kB pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of IKB and the nuclear translocation of NF-kB p65 [106].",
      "key": "84cda7e08d66b832e31ae4f177243054",
      "line": 165,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 18,
      "target": 98
    },
    {
      "key": "e097cfc5d22b2a48d88491a299a63265",
      "relation": "hasVariant",
      "source": 93,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-kB inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and alpha activiies [181,182]. ",
      "key": "c5cee6a362bed62972065eb29fc891c9",
      "line": 400,
      "object": {
        "location": {
          "name": "Cytosol",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 93,
      "target": 73
    },
    {
      "key": "3a816dbaf4bbd02c74af7c35b9a7ea80",
      "relation": "hasVariant",
      "source": 98,
      "target": 99
    },
    {
      "key": "0f97f0e23028811ee21a013fd131684a",
      "relation": "hasVariant",
      "source": 98,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-a, COX2 and interleukins [113,114].",
      "key": "dc0eef7f251338eab8cbf56bda5a53f6",
      "line": 173,
      "relation": "decreases",
      "source": 25,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-a, COX2 and interleukins [113,114].",
      "key": "8f860309a174cf14603ed77341c9d9f5",
      "line": 174,
      "relation": "decreases",
      "source": 25,
      "target": 97
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in Ab-activated glial cells. All these effects were attributable to their suppression of nuclear NF-kB translocation [116].",
      "key": "6ae99ffc26399e7122d6162b207330d6",
      "line": 203,
      "relation": "decreases",
      "source": 25,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-a, COX2 and interleukins [113,114].",
      "key": "cc65272c699c14e28e12680cd28076d8",
      "line": 175,
      "relation": "decreases",
      "source": 25,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and IkB through LPS stimulation and subse-quently inhibited the activity of NF-kB [115].",
      "key": "e213c48a336d7f05e0a21926ef0e02d0",
      "line": 182,
      "relation": "decreases",
      "source": 25,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and IkB through LPS stimulation and subse-quently inhibited the activity of NF-kB [115].",
      "key": "daae7fb308c42faf50cc2780f8e936c3",
      "line": 183,
      "relation": "decreases",
      "source": 25,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and IkB through LPS stimulation and subse-quently inhibited the activity of NF-kB [115].",
      "key": "d3cbfd5d4b5746e05fef8d5a42ff451d",
      "line": 184,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 25,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Resveratrol disrupted the phosphorylation of signal transducer and activator of transcription factor 1 (STAT1) and STAT3 [115].",
      "key": "c4b4b74aeef862485ff9546cf280ab2e",
      "line": 190,
      "relation": "decreases",
      "source": 25,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Resveratrol disrupted the phosphorylation of signal transducer and activator of transcription factor 1 (STAT1) and STAT3 [115].",
      "key": "d303c594f15639ab8dc3a01c67ebb8f5",
      "line": 191,
      "relation": "decreases",
      "source": 25,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in Ab-activated glial cells. All these effects were attributable to their suppression of nuclear NF-kB translocation [116].",
      "key": "83bb9529d696ec0046e223e55f8c9a7c",
      "line": 198,
      "relation": "decreases",
      "source": 25,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in Ab-activated glial cells. All these effects were attributable to their suppression of nuclear NF-kB translocation [116].",
      "key": "ba80cb52ea2bfdb5d2e55fc8749b195c",
      "line": 199,
      "relation": "decreases",
      "source": 25,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in Ab-activated glial cells. All these effects were attributable to their suppression of nuclear NF-kB translocation [116].",
      "key": "b4bcfeea3e579769038327291d0601a2",
      "line": 202,
      "relation": "decreases",
      "source": 25,
      "target": 10
    },
    {
      "key": "914f33bb078e43f32c8c7d3bf8caefd5",
      "relation": "hasVariant",
      "source": 61,
      "target": 62
    },
    {
      "key": "cfa37957aea17309bdf3884196eed1fd",
      "relation": "hasVariant",
      "source": 101,
      "target": 102
    },
    {
      "key": "b4fdec3e6886d306d2bab20f4a94b773",
      "relation": "hasVariant",
      "source": 103,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR-a regulation [118,119], NF-kB transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "a2271bc70f619aa3ebe4e9b4a2302013",
      "line": 211,
      "relation": "regulates",
      "source": 24,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR-a regulation [118,119], NF-kB transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "33f77aa30d87f361e9a1284568383f82",
      "line": 212,
      "relation": "regulates",
      "source": 24,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR-a regulation [118,119], NF-kB transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "0406449b8624b477b84ad8f2ca292441",
      "line": 213,
      "relation": "regulates",
      "source": 24,
      "target": 71
    },
    {
      "key": "2f5ac5955c1f8378aa2b5ab4aa4f0266",
      "relation": "hasVariant",
      "source": 70,
      "target": 71
    },
    {
      "annotations": {
        "CellLine": {
          "cancer cell line": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Punicalagin decreased the expression of COX2 and DNA binding of NF-kB in human colon cancer cell line [126].",
      "key": "9476fe46d050ab2e4c8304e227a465ff",
      "line": 222,
      "relation": "decreases",
      "source": 43,
      "target": 127
    },
    {
      "annotations": {
        "CellLine": {
          "cancer cell line": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Punicalagin decreased the expression of COX2 and DNA binding of NF-kB in human colon cancer cell line [126].",
      "key": "a2b56272ab1503c66bda1b22809e5616",
      "line": 223,
      "object": {
        "effect": {
          "name": "DNA binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 43,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "astrocyte": true,
          "macrophage": true,
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Inﬂammation caused by LPS was reduced with treatment of punicalaginin RAW264.7 macrophages, astrocytes and microglial BV-2 cells",
      "key": "65d05f1b6e9e6e7801e12f3f8c2093e7",
      "line": 233,
      "relation": "decreases",
      "source": 43,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-kB pathway and activated the phosphorylation of IkBk, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "a621d4e066a92dc1f9b0b6bf962c01c2",
      "line": 240,
      "relation": "decreases",
      "source": 8,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-kB pathway and activated the phosphorylation of IkBk, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "3e7435b8360864bd3535f53d71d7f92f",
      "line": 241,
      "relation": "increases",
      "source": 8,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-kB pathway and activated the phosphorylation of IkBk, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "f6f73653417d02e52210ec09ef833009",
      "line": 242,
      "relation": "increases",
      "source": 8,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-kB pathway and activated the phosphorylation of IkBk, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "7c6d615d872eb882b63c86b39893c259",
      "line": 243,
      "relation": "increases",
      "source": 8,
      "target": 67
    },
    {
      "key": "7b8d43894a2512b47964f575f56e572e",
      "relation": "hasVariant",
      "source": 90,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "6ab1e0a22e53e05305319fb3c2056a34",
      "line": 252,
      "relation": "increases",
      "source": 15,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "fa0509cabf9df8a9a7016ecbafede92a",
      "line": 254,
      "relation": "regulates",
      "source": 15,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "da737c43812be4675eaefbfc95eadc9a",
      "line": 255,
      "relation": "regulates",
      "source": 15,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "160522c52ca8476122ada9286aed9007",
      "line": 256,
      "relation": "regulates",
      "source": 15,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "70e482487712295d1ae741232e5b7642",
      "line": 257,
      "relation": "regulates",
      "source": 15,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "5c775c2ab5526d516b969cda5acfc24d",
      "line": 258,
      "relation": "regulates",
      "source": 15,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-kB pathway proteins such as NF-kB p65, IkBk, IKKa and IKKb[137].",
      "key": "d3c4384147cdcf34d1c78d3d1abf3ed1",
      "line": 259,
      "relation": "regulates",
      "source": 15,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of Ab aggregation in Ab 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "6039d9cc3c3358dfa53423edc4642ad0",
      "line": 270,
      "relation": "increases",
      "source": 34,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of Ab aggregation in Ab 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "97017a2512dba8fceb7959f5869f069a",
      "line": 271,
      "relation": "decreases",
      "source": 34,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of Ab aggregation in Ab 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "1148d8cd7c9fd14e18a833f62c592e39",
      "line": 272,
      "relation": "decreases",
      "source": 34,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of Ab aggregation in Ab 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "4d1a1b0b509876d8ecc6034e51d671ae",
      "line": 273,
      "relation": "decreases",
      "source": 34,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "LPS-stimulated memory impairments were improved by 4-O-methylhonokinol through the inhibition of Ab 1-42 expression. ",
      "key": "f5e4c523cc42f1d0e453eb67e54558a9",
      "line": 281,
      "relation": "decreases",
      "source": 34,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inactivated gamma– and beta-secretases and astrocytes through the inter-ference of NF-kB activation [144",
      "key": "75af50b09f201bd5160fd5a89204731e",
      "line": 288,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inactivated gamma– and beta-secretases and astrocytes through the inter-ference of NF-kB activation [144",
      "key": "df9e44946f7c179178a61a8d54e849da",
      "line": 289,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inactivated gamma– and beta-secretases and astrocytes through the inter-ference of NF-kB activation [144",
      "key": "36ee6baa96b61c319903de45c7a2c02f",
      "line": 290,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "LPS-stimulated memory impairments were improved by 4-O-methylhonokinol through the inhibition of Ab 1-42 expression. ",
      "key": "f9f43a16a19a1f757787986b80d0ace0",
      "line": 282,
      "relation": "association",
      "source": 56,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "LPS-stimulated memory impairments were improved by 4-O-methylhonokinol through the inhibition of Ab 1-42 expression. ",
      "key": "04ea445aa61409133393b94bf066d362",
      "line": 282,
      "relation": "association",
      "source": 5,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, the level of Ab 1-42 was lowered by L-theanine and caused Ab 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "34b7948c9a65be04d15e5c8b4dbc25a6",
      "line": 762,
      "relation": "increases",
      "source": 5,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It improved ICV Ab 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-kB signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "1da5aeb2e37af96f1fefbbf98436e113",
      "line": 297,
      "relation": "increases",
      "source": 21,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It improved ICV Ab 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-kB signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "90e02ab94fe27a6c9a59fe936b982d05",
      "line": 298,
      "relation": "increases",
      "source": 21,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It improved ICV Ab 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-kB signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "7b7ba8ae36c81680864250b2dee94b8f",
      "line": 299,
      "relation": "decreases",
      "source": 21,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It improved ICV Ab 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-kB signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "27af99203f165c77fefcf3845dd782ff",
      "line": 300,
      "relation": "decreases",
      "source": 21,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated Ab 25-35-stimulated TLR4 and NF-kB expres-sion, DNA binding and NF-kB activities[159].",
      "key": "1223fb652f9c9b9c1647e2d13c4effcb",
      "line": 307,
      "relation": "decreases",
      "source": 20,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated Ab 25-35-stimulated TLR4 and NF-kB expres-sion, DNA binding and NF-kB activities[159].",
      "key": "ba4f56bacf7395450a02fdf103336f58",
      "line": 308,
      "relation": "decreases",
      "source": 20,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated Ab 25-35-stimulated TLR4 and NF-kB expres-sion, DNA binding and NF-kB activities[159].",
      "key": "812eb1570b91b3c29f5c5b8cb075f49d",
      "line": 309,
      "object": {
        "effect": {
          "name": "DNA binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated Ab 25-35-stimulated TLR4 and NF-kB expres-sion, DNA binding and NF-kB activities[159].",
      "key": "daf583693c20cbc0feb10bc2d803c3fc",
      "line": 310,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "ICV infusion of impairments by Ab 1-42 was considerably reduced with the treatment of obovatol [161].",
      "key": "8e3f839cbce50f06fc8917d8286b297f",
      "line": 316,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 44,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "e7d70aab82790b4e2c058dc98a40ce64",
      "line": 324,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "11c369d650015e3bdafc1408f423dbcd",
      "line": 325,
      "relation": "decreases",
      "source": 7,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "738c44e6326477aac4182df8dae0ef2f",
      "line": 326,
      "relation": "decreases",
      "source": 7,
      "target": 117
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab-activated NF-kB activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced Ab-activated neu-rotoxicity [164].",
      "key": "00c60dd969f887bfa0438e0d6f18a43f",
      "line": 335,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab-activated NF-kB activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced Ab-activated neu-rotoxicity [164].",
      "key": "17e4e76f8c86c129ab2ccb19556316be",
      "line": 336,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab-activated NF-kB activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced Ab-activated neu-rotoxicity [164].",
      "key": "cf877fc2f4d28404a5ae63daa46a0038",
      "line": 338,
      "relation": "association",
      "source": 99,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab-activated NF-kB activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced Ab-activated neu-rotoxicity [164].",
      "key": "ee33168bf18f076d16dcdc876f085018",
      "line": 338,
      "relation": "association",
      "source": 113,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibits AChE competitively and reversibly, causing elevated cerebral concen-trations of ACh, and thus, enhancing cholinergic activity. ",
      "key": "5647742601c4a79ea8e1092efae231d2",
      "line": 345,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 19,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibits AChE competitively and reversibly, causing elevated cerebral concen-trations of ACh, and thus, enhancing cholinergic activity. ",
      "key": "0fdfea78c50f38867dfc51aab759310e",
      "line": 347,
      "relation": "increases",
      "source": 19,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, galantamine allosterically interacted with nicotinic ACh receptors to increase the agonistic activity of these receptors and ampliﬁed the ACh reaction through stimulating ACh release [165–167].",
      "key": "b56cf2aa0133528462ac7ee25a05db3d",
      "line": 358,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 19,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibits AChE competitively and reversibly, causing elevated cerebral concen-trations of ACh, and thus, enhancing cholinergic activity. ",
      "key": "43a66ac2caba8a43bcef46779e3ca917",
      "line": 348,
      "relation": "increases",
      "source": 19,
      "target": 27
    },
    {
      "key": "abebc8f88e09c34f4faae15889735009",
      "relation": "partOf",
      "source": 19,
      "target": 57
    },
    {
      "annotations": {
        "Cell": {
          "brain microvascular endothelial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The protective effects of galantamine in brain microvascular endothelial cells were mediated via protective gene, heme oxygenase-1 induction through NF-kB activation [168]",
      "key": "68a95dfa03faf9fe164a695cfe717770",
      "line": 366,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 19,
      "target": 82
    },
    {
      "annotations": {
        "Cell": {
          "brain microvascular endothelial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The protective effects of galantamine in brain microvascular endothelial cells were mediated via protective gene, heme oxygenase-1 induction through NF-kB activation [168]",
      "key": "8cdb52d92ee36ed24b33875254780ed1",
      "line": 367,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 19,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, galantamine allosterically interacted with nicotinic ACh receptors to increase the agonistic activity of these receptors and ampliﬁed the ACh reaction through stimulating ACh release [165–167].",
      "key": "5c9344f4997e6a4b4c500996536863e6",
      "line": 357,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 57,
      "target": 65
    },
    {
      "key": "cb3c4fd6d3eae2b0fd0b3e8d2246c13a",
      "relation": "partOf",
      "source": 65,
      "target": 57
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "dea97e6fd57fc3d2d7e57c733f2dde12",
      "line": 377,
      "relation": "decreases",
      "source": 33,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "8080ef0e0c5c36abfc232e6427ff7872",
      "line": 378,
      "relation": "decreases",
      "source": 33,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "8932acef6c0c2aa1b1a34baac65f7cf1",
      "line": 379,
      "relation": "decreases",
      "source": 33,
      "target": 85
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "1fbab53a6f4d47b3e30de7a12c5a91f2",
      "line": 380,
      "relation": "decreases",
      "source": 33,
      "target": 97
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "5f806a5bdcf1bf76ce0c8a94a1f5f0be",
      "line": 381,
      "relation": "decreases",
      "source": 33,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "d9357a5a4c9ffb8d9417fa6a3b07f44d",
      "line": 382,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "20d1398d2804820ecde09a982a9db611",
      "line": 383,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 90
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-a, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-kB, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "2073c3b20f1b81f0a2896610a62cc987",
      "line": 384,
      "relation": "decreases",
      "source": 33,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tetrandrine inhibited the activity of NF-kB and down-regulated the expression of pro-inﬂammatory cytokines [178–180].",
      "key": "386a012bf0ad4af0dd87b891eee2a271",
      "line": 391,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 45,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by Ab 1-42 and was associated with the inter-ference of NF-kB activity and the inhibition of IL-1b and TNF-a expression [183].",
      "key": "1fed549322892cad69b48a2caa6c3801",
      "line": 412,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 45,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tetrandrine inhibited the activity of NF-kB and down-regulated the expression of pro-inﬂammatory cytokines [178–180].",
      "key": "4f96e5e84631fa8c8f3cf5a370ffb072",
      "line": 392,
      "relation": "decreases",
      "source": 45,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-kB inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and alpha activiies [181,182]. ",
      "key": "3ef666faeecf37ad064f2fb1bcaccb6a",
      "line": 399,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 45,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-kB inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and alpha activiies [181,182]. ",
      "key": "099c76f634166fc20396fe81c0c9733c",
      "line": 401,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 45,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-kB inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and alpha activiies [181,182]. ",
      "key": "cea6a398707674b947885571e24d8bf4",
      "line": 402,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 45,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-kB inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and alpha activiies [181,182]. ",
      "key": "f5cd57c8e24e71626b8a8e5e4a709c87",
      "line": 403,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 45,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by Ab 1-42 and was associated with the inter-ference of NF-kB activity and the inhibition of IL-1b and TNF-a expression [183].",
      "key": "59a615e2c55ad7fce22cf74fcc58b46d",
      "line": 410,
      "relation": "increases",
      "source": 45,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by Ab 1-42 and was associated with the inter-ference of NF-kB activity and the inhibition of IL-1b and TNF-a expression [183].",
      "key": "079820e4b370f788f895d6c95123644a",
      "line": 411,
      "relation": "increases",
      "source": 45,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by Ab 1-42 and was associated with the inter-ference of NF-kB activity and the inhibition of IL-1b and TNF-a expression [183].",
      "key": "13c38a57de1ac39ab1c52be3a841dd3c",
      "line": 413,
      "relation": "decreases",
      "source": 45,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by Ab 1-42 and was associated with the inter-ference of NF-kB activity and the inhibition of IL-1b and TNF-a expression [183].",
      "key": "45b5f94f957e1668512e3815d31cf511",
      "line": 414,
      "relation": "decreases",
      "source": 45,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Berberine suppressed inﬂammatory events occurring in several inﬂammation-related diseases [186,187].",
      "key": "846f7fffb6d9972fe503e0b285ec6308",
      "line": 420,
      "relation": "decreases",
      "source": 17,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, berberine decreased the phosphorylation and expression of p65 [188].",
      "key": "d8e4ac36483d0621abb988a39b70e43c",
      "line": 426,
      "relation": "decreases",
      "source": 17,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, berberine decreased the phosphorylation and expression of p65 [188].",
      "key": "9d6d3dbd022986b699004634defcf882",
      "line": 427,
      "relation": "decreases",
      "source": 17,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Also, berberine inhibited the phosphorylation of IkBk.",
      "key": "16839aaa4aa8957f58bbe9c496c6d631",
      "line": 432,
      "relation": "decreases",
      "source": 17,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by Ab",
      "key": "4efff9a0ffb54031eff9951338e11f67",
      "line": 438,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by Ab",
      "key": "35ce32b15daed00f0c639c5992e4de30",
      "line": 439,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by Ab",
      "key": "b06c8e64ae95f28a30b8cf2c865e4f40",
      "line": 440,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 64
    },
    {
      "annotations": {
        "CellLine": {
          "HepG2": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of NF-kB in TNF-a induced HepG2 cells [193].",
      "key": "b0d9adbe5b337b5c10bdddade6d9b9d1",
      "line": 447,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 23,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it attenuated cognitive disorders nd inﬂam-matory reactions in Ab 1-42-activated AD mice[194].",
      "key": "3b942f10fa0d68170f47808350e8c15a",
      "line": 457,
      "relation": "increases",
      "source": 23,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it attenuated cognitive disorders nd inﬂam-matory reactions in Ab 1-42-activated AD mice[194].",
      "key": "07aaba1ec63c7363c81d712129855935",
      "line": 458,
      "relation": "decreases",
      "source": 23,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Anatabine lowered NF-kB activation by inhibiting Ab production in vitro [195].",
      "key": "19806135f4f994c3f0696f064f0eccbc",
      "line": 466,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 13,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Anatabine lowered NF-kB activation by inhibiting Ab production in vitro [195].",
      "key": "f854a8e891adb912bf4da361624cfbc4",
      "line": 467,
      "relation": "decreases",
      "source": 13,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It con-siderably lowered the expression of Ab 1-40 and Ab 1-42 in an AD transgenic mouse [195].",
      "key": "d5c778b02bf3a132f3f3f249d2664d9c",
      "line": 475,
      "relation": "decreases",
      "source": 13,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It con-siderably lowered the expression of Ab 1-40 and Ab 1-42 in an AD transgenic mouse [195].",
      "key": "20a2a8ecf153bee9e5f3be97c089d87a",
      "line": 476,
      "relation": "decreases",
      "source": 13,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-kB inﬂamma-tory pathway in Ab 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "d764414b732c49aa27df970a2123eb6d",
      "line": 487,
      "relation": "decreases",
      "source": 12,
      "target": 74
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-kB inﬂamma-tory pathway in Ab 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "28201b232ccee5f906d9deed2be595c2",
      "line": 488,
      "relation": "decreases",
      "source": 12,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-kB inﬂamma-tory pathway in Ab 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "9df273a89f0d9d55cd1d1ac7c5b9d501",
      "line": 489,
      "relation": "decreases",
      "source": 12,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It has antiox-idant effects via the interference of reactive components and ROS by redox cycling of quinine, and subsequently generating hydroquinone [209].",
      "key": "0cfac617d19ae31bb7af3d607c573b35",
      "line": 497,
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Neuroblastoma": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Reduction of Ab expression and cytotoxic-ity stimulated by Ab in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with a-tocopherol [210].",
      "key": "8612a521af011ba80aa808e274ceafed",
      "line": 505,
      "relation": "decreases",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Oxidative stress and Ab expression were suppressed with a-tocopherol in mouse model.",
      "key": "b9e5033842ad9d2f246c93420c9c7509",
      "line": 526,
      "relation": "decreases",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Reduction of Ab expression and cytotoxic-ity stimulated by Ab in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with a-tocopherol [210].",
      "key": "eec13c889b9ad15be57e06cca28c964c",
      "line": 508,
      "relation": "decreases",
      "source": 3,
      "target": 29
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Reduction of Ab expression and cytotoxic-ity stimulated by Ab in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with a-tocopherol [210].",
      "key": "215d82b32bfdd8bc644906211f7e9a61",
      "line": 509,
      "relation": "decreases",
      "source": 3,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Memory deﬁ-ciencies were improved by a-tocopherol in transgenic mice.",
      "key": "533881d1a01a7c3e8c0a8ed446419671",
      "line": 517,
      "relation": "increases",
      "source": 3,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Oxidative stress and Ab expression were suppressed with a-tocopherol in mouse model.",
      "key": "85422046766285a1fe6d24e9f524529f",
      "line": 525,
      "relation": "decreases",
      "source": 3,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-kB, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1a, and the reduction of microglial activation [37]",
      "key": "1c6fa32f67501aa01b5e9fa35b4e0cd3",
      "line": 536,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-kB, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1a, and the reduction of microglial activation [37]",
      "key": "66094ae98ca017b0b7dd93ecaff5f17b",
      "line": 537,
      "relation": "decreases",
      "source": 3,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-kB, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1a, and the reduction of microglial activation [37]",
      "key": "564b46cd2f0b679377fc025176ec4fa9",
      "line": 538,
      "relation": "decreases",
      "source": 3,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-kB, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1a, and the reduction of microglial activation [37]",
      "key": "e1dba626bb9769c4dbc009a67ea535d0",
      "line": 539,
      "relation": "decreases",
      "source": 3,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-kB, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1a, and the reduction of microglial activation [37]",
      "key": "b906fc4b197ffc01e95d65b7fb756f71",
      "line": 540,
      "relation": "decreases",
      "source": 3,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-a [216–219] and mod-ulating NF-kB signaling [220,221].",
      "key": "58cbf0cb8153b4afeb14f43ce7c61449",
      "line": 547,
      "relation": "decreases",
      "source": 42,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-a [216–219] and mod-ulating NF-kB signaling [220,221].",
      "key": "d7223050924a86dfd40593cb291c5921",
      "line": 548,
      "relation": "decreases",
      "source": 42,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-a [216–219] and mod-ulating NF-kB signaling [220,221].",
      "key": "45722fcc61f1ec358c7286ac40fd08e0",
      "line": 549,
      "relation": "decreases",
      "source": 42,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-a [216–219] and mod-ulating NF-kB signaling [220,221].",
      "key": "ece8de5c248b9fcc44a11539d05781f3",
      "line": 550,
      "relation": "decreases",
      "source": 42,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-a [216–219] and mod-ulating NF-kB signaling [220,221].",
      "key": "b425444f357b7561f7b1d437ebb3b236",
      "line": 551,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 42,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It reduced BACE1 expression and repressed LPS-activated nuclear translocation of NF-kB and its binding to the BACE1 promoter [222].",
      "key": "d8a3581c0757f75c1afe4ec12ea8b96c",
      "line": 559,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 42,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It reduced BACE1 expression and repressed LPS-activated nuclear translocation of NF-kB and its binding to the BACE1 promoter [222].",
      "key": "3379ce98cf3c4fc9ef907f70c8e215a1",
      "line": 558,
      "relation": "decreases",
      "source": 42,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It reduced BACE1 expression and repressed LPS-activated nuclear translocation of NF-kB and its binding to the BACE1 promoter [222].",
      "key": "f606bbc545ea96496a9563f6b6ff403f",
      "line": 560,
      "relation": "decreases",
      "source": 42,
      "target": 58
    },
    {
      "key": "8f1613d989083177a02644d5915acbf2",
      "relation": "partOf",
      "source": 59,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "fd8e71684a938bd215a05ab2ab0b861b",
      "line": 568,
      "relation": "decreases",
      "source": 37,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "492371ce2833d81b17e490406e0eca94",
      "line": 569,
      "relation": "decreases",
      "source": 39,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "111184dfad55a88b3d501055649a4cb2",
      "line": 570,
      "relation": "decreases",
      "source": 46,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ab levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "097a041c0343f2766a07d9e4792d0a2c",
      "line": 571,
      "relation": "decreases",
      "source": 40,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "afdbc53da9cc082d210f73cb9c3fe595",
      "line": 598,
      "relation": "decreases",
      "source": 40,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "264c02c1b8f6b4b6f7fdd10d0f42316f",
      "line": 599,
      "relation": "decreases",
      "source": 40,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "c5520f393a5745d25c79b9b71a6b873c",
      "line": 600,
      "relation": "decreases",
      "source": 40,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "81379ddc89dfca7c312a25fbb4184744",
      "line": 601,
      "relation": "decreases",
      "source": 40,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "5a7aa3e058ec75e37ab909344b138fbf",
      "line": 602,
      "relation": "decreases",
      "source": 40,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "7d1bc9406898efd7b17db72ac4797e91",
      "line": 603,
      "relation": "decreases",
      "source": 40,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "4ba78ef09181f6e9a0a1de3047ac1006",
      "line": 604,
      "relation": "decreases",
      "source": 40,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "c637de332c4788f861427cc3061f1826",
      "line": 605,
      "relation": "decreases",
      "source": 40,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "1958b9871def14ac2f657f5d3cfef156",
      "line": 606,
      "relation": "decreases",
      "source": 40,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-kB and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-a and IFN-b [227]",
      "key": "0817434a1976115fd2b162f38ef5c6a8",
      "line": 607,
      "relation": "decreases",
      "source": 40,
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with Ab 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-kB [226].",
      "key": "a33df13b466cd8d1fcf6b797c8da226a",
      "line": 583,
      "relation": "decreases",
      "source": 36,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with Ab 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-kB [226].",
      "key": "72e2a3fabc6e9de244b303e3088c592a",
      "line": 586,
      "relation": "increases",
      "source": 36,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with Ab 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-kB [226].",
      "key": "4d074bc00f2c43e5f28d4926138f63a8",
      "line": 587,
      "relation": "increases",
      "source": 36,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with Ab 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-kB [226].",
      "key": "117cd52456158164abfdd84a80649617",
      "line": 588,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 36,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-kBp65 and consequently prevent AD in the brain [229–231].",
      "key": "9e7b911e5d20695ba84cb75d59e3e105",
      "line": 613,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 35,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-kBp65 and consequently prevent AD in the brain [229–231].",
      "key": "c11b117e9205e1818b0a8e3105cd172d",
      "line": 614,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 35,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-kBp65 and consequently prevent AD in the brain [229–231].",
      "key": "c6cb7eebc8ddcd24704358bd6018cb9a",
      "line": 615,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 35,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-kBp65 and consequently prevent AD in the brain [229–231].",
      "key": "9e0b1e5f6173d1a920a05f7e9b2f8640",
      "line": 617,
      "relation": "decreases",
      "source": 35,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in Ab 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "c364ca68a77fc9273c73bafe7051681f",
      "line": 626,
      "relation": "decreases",
      "source": 35,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Atherosclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in Ab 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "2b3b5fa1501bfdde636625680d9b57b2",
      "line": 628,
      "relation": "decreases",
      "source": 35,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Brain Ischemia": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in Ab 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "a7c55dc302a42028f9f7b13ae1e267fc",
      "line": 630,
      "relation": "decreases",
      "source": 35,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-kB and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and IkB in AD [235,236].",
      "key": "33894482107a637d9929a247517d4366",
      "line": 639,
      "relation": "decreases",
      "source": 35,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-kB and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and IkB in AD [235,236].",
      "key": "3026c2cb36d25e3269c3d779fd0a4930",
      "line": 640,
      "relation": "decreases",
      "source": 35,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-kB and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and IkB in AD [235,236].",
      "key": "ba840a50b6c5a09bc1f52f606d33e826",
      "line": 641,
      "relation": "increases",
      "source": 35,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-kB and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and IkB in AD [235,236].",
      "key": "40b79937439fd5dc0f6e428ce6b81743",
      "line": 642,
      "relation": "increases",
      "source": 35,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-kB and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and IkB in AD [235,236].",
      "key": "8609f660b5d4213df7cbb59ceb5cbad9",
      "line": 643,
      "relation": "increases",
      "source": 35,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover,it reveals promising anti-inﬂammatory actions through suppress-ing the activation of NF-kB [238–240]. ",
      "key": "8667ce71e4f38b3455483318f11936ff",
      "line": 650,
      "relation": "decreases",
      "source": 0,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover,it reveals promising anti-inﬂammatory actions through suppress-ing the activation of NF-kB [238–240]. ",
      "key": "373af8fcfa307d35e526ea05c3e691bc",
      "line": 651,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 0,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of Ab was lowered by artemisinin through inhibition of the activity of NALP3 inﬂammasome in APPswe/PS1\u0002E9 transgenic mice [241].",
      "key": "f5430d7723464cc2bdecfcd801b6c751",
      "line": 659,
      "relation": "decreases",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of Ab was lowered by artemisinin through inhibition of the activity of NALP3 inﬂammasome in APPswe/PS1\u0002E9 transgenic mice [241].",
      "key": "526877447dcc4b56baf66e9ca5c9267b",
      "line": 660,
      "relation": "decreases",
      "source": 0,
      "target": 48
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "1fc03c1c5ff09bb46f1cefca6820e1ec",
      "line": 671,
      "relation": "decreases",
      "source": 38,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "76bed900c3d3ab02b2d5f012c9304376",
      "line": 672,
      "relation": "decreases",
      "source": 38,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "1ca1656f4a99e66e4d57aaa054df2709",
      "line": 673,
      "relation": "decreases",
      "source": 38,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "4b6ba4f4ecb40b90cab1db694fa241f8",
      "line": 674,
      "relation": "decreases",
      "source": 38,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "153234fa8ca4ca8a74298b57b8c82503",
      "line": 675,
      "relation": "decreases",
      "source": 38,
      "target": 97
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-a, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "c4debd65ed849f46c7a91d1cce3cc166",
      "line": 676,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 38,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-kB signaling[243].",
      "key": "effd02e186c0c1c9104cfe73e4e4e8f4",
      "line": 683,
      "relation": "decreases",
      "source": 38,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-kB signaling[243].",
      "key": "59dda07a9176b2c8ed0ea5f4fe79c3e3",
      "line": 684,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 38,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-kB signaling[243].",
      "key": "9516af34896c9294fb7acff5cf80e878",
      "line": 685,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 38,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-kB signaling[243].",
      "key": "e676c05f27f33e94757727210b4b7d1e",
      "line": 686,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 38,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "f5e9fd294adb663c1defcef1b1420662",
      "line": 693,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "efe32f9077bd9767f5e45793762ad714",
      "line": 694,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "0aab50736ad5c40813fa6d77e150d54f",
      "line": 695,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "a9cdc869ed7a6d4e1bcb1c4e38b98f0b",
      "line": 696,
      "relation": "decreases",
      "source": 14,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "5795514c58c769d7c3f5421e63332980",
      "line": 697,
      "relation": "decreases",
      "source": 14,
      "target": 122
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and IkB/NF-kB, the expression of TNF-a, IL-1a and cerebral Ab accumulation in vivo[245]",
      "key": "11993b4b92d73eedf9117233cb9dc9c7",
      "line": 699,
      "relation": "decreases",
      "source": 14,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside alleviated the Ab 25-35-stimulated spatial memory deﬁciencies and oxidative stress in mouse models [246].",
      "key": "f99e58aebdfaac32c9fc17597c934f14",
      "line": 708,
      "relation": "increases",
      "source": 32,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside alleviated the Ab 25-35-stimulated spatial memory deﬁciencies and oxidative stress in mouse models [246].",
      "key": "7f45bb0e0aff2d3dc7571ed558195251",
      "line": 709,
      "relation": "decreases",
      "source": 32,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "d3f4331ab860d17a7f68f5eb5fd519e4",
      "line": 719,
      "relation": "decreases",
      "source": 32,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "05614374af571bf9375d14bac0e3566a",
      "line": 720,
      "relation": "decreases",
      "source": 32,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "3da64269043b5a488da9b07f3a2c59f6",
      "line": 721,
      "relation": "increases",
      "source": 32,
      "target": 123
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Furthermore, it inhibited pro-inﬂammatory cytokines, which were induced by Ab 25-35/IFN-b in microglia cells [248].",
      "key": "1b3aa04777447d98bad494e4f72c94c5",
      "line": 729,
      "relation": "decreases",
      "source": 32,
      "target": 29
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of Ab 25-35/IFN-b-stimulated NO, IL-1b,and TNF-a in microglia, which implicated the down-regulation of the activities of MAPK and NF-kB pathways [248]",
      "key": "1d20b47d98e513cea59b1cfefae40959",
      "line": 738,
      "relation": "decreases",
      "source": 32,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of Ab 25-35/IFN-b-stimulated NO, IL-1b,and TNF-a in microglia, which implicated the down-regulation of the activities of MAPK and NF-kB pathways [248]",
      "key": "25d9c80c70d0194a848add3d6c298892",
      "line": 739,
      "relation": "decreases",
      "source": 32,
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of Ab 25-35/IFN-b-stimulated NO, IL-1b,and TNF-a in microglia, which implicated the down-regulation of the activities of MAPK and NF-kB pathways [248]",
      "key": "59ce74f64fed8729ff8425534ee0acd6",
      "line": 740,
      "relation": "decreases",
      "source": 32,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of Ab 25-35/IFN-b-stimulated NO, IL-1b,and TNF-a in microglia, which implicated the down-regulation of the activities of MAPK and NF-kB pathways [248]",
      "key": "07bbc7d904407bc76338a460a75dada6",
      "line": 741,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 66
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of Ab 25-35/IFN-b-stimulated NO, IL-1b,and TNF-a in microglia, which implicated the down-regulation of the activities of MAPK and NF-kB pathways [248]",
      "key": "7f948d8cff369a35d0f7838b4a8c4953",
      "line": 742,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It considerably decreased Ab 1-42-stimulated memory disorders in mice [128].",
      "key": "8df14e00a329a9a8a524715f804f39f1",
      "line": 751,
      "relation": "increases",
      "source": 2,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, the level of Ab 1-42 was lowered by L-theanine and caused Ab 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "0a267d643fa308d75fd35c43fa2f4fb2",
      "line": 760,
      "relation": "decreases",
      "source": 2,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Moreover, the level of Ab 1-42 was lowered by L-theanine and caused Ab 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "638f9ae9ce7e638a500f30537d3d4bc2",
      "line": 763,
      "relation": "decreases",
      "source": 2,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-kB pathway were disrupted byL-theanine [128].",
      "key": "49ce5ca6f8159f8f434921c25377b7c3",
      "line": 770,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-kB pathway were disrupted byL-theanine [128].",
      "key": "e04979ebc93273709b66fae9be908e38",
      "line": 771,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-kB pathway were disrupted byL-theanine [128].",
      "key": "0758ce0c158c700c6c4eb17e5c3204a6",
      "line": 772,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The mitochondrial membrane potential, ROS and NO levels were down-regulated by 1,8-cineole in Ab 25-35-stimulated cells [250].",
      "key": "2c47e1c38912a22b1cbb37b44029d21e",
      "line": 779,
      "relation": "decreases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The mitochondrial membrane potential, ROS and NO levels were down-regulated by 1,8-cineole in Ab 25-35-stimulated cells [250].",
      "key": "eb5f61266c2ea1376de7c52535c47242",
      "line": 780,
      "relation": "decreases",
      "source": 1,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-a, IL-1b and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in Ab 25-35-induced cells [250].",
      "key": "5387d6bd1bfb66b08f1cfad34905b5f3",
      "line": 789,
      "relation": "decreases",
      "source": 1,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-a, IL-1b and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in Ab 25-35-induced cells [250].",
      "key": "55d36db5852f9a3c28eb84464867f2a6",
      "line": 790,
      "relation": "decreases",
      "source": 1,
      "target": 122
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-a, IL-1b and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in Ab 25-35-induced cells [250].",
      "key": "8776be356f6c585ff0533f581869a25f",
      "line": 791,
      "relation": "decreases",
      "source": 1,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-kB was reduced by1,8-cineole [250].",
      "key": "12b6b0886a39154c6e49e106ebc2b548",
      "line": 798,
      "relation": "decreases",
      "source": 1,
      "target": 126
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-kB was reduced by1,8-cineole [250].",
      "key": "04e377416ca2d1325ac9d75da9d13b44",
      "line": 799,
      "relation": "decreases",
      "source": 1,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-kB was reduced by1,8-cineole [250].",
      "key": "c50e02ca26861e3e036b7e5b2e6b2d34",
      "line": 800,
      "relation": "decreases",
      "source": 1,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Paeoniﬂorin improved memory impairments and lowered Ab accumulation in APP/PS1 trans-genic mice [1].",
      "key": "85b9acff097311613517c713d214b8f6",
      "line": 808,
      "relation": "increases",
      "source": 41,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "Paeoniﬂorin improved memory impairments and lowered Ab accumulation in APP/PS1 trans-genic mice [1].",
      "key": "64fa0180235093dd9055a2da58c0efec",
      "line": 809,
      "relation": "decreases",
      "source": 41,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "77a9d6ebdc94ad60f4df339897faca95",
      "line": 818,
      "relation": "decreases",
      "source": 41,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "ed8ff6257ff277e3465e92158cdee321",
      "line": 819,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 41,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "10cddde66e5950ae96c028a0485b72e0",
      "line": 820,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 41,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "145ec3de5b0f63cc9b2126c616ac2a11",
      "line": 821,
      "relation": "decreases",
      "source": 41,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "0e9f6460a82931bb64a2e43091c70e74",
      "line": 822,
      "relation": "decreases",
      "source": 41,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "db": "PubMed",
        "db_id": "29179999",
        "db_name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "first": "Seo EJ",
        "journal": "Pharmacological research",
        "last": "Efferth T",
        "pages": "262-273",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-kB activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-a and IL-1b\u0003 [1].",
      "key": "d98b032e43626c547ab2a77d2d9e1b37",
      "line": 823,
      "relation": "decreases",
      "source": 41,
      "target": 86
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(+)-artemisinin\")",
      "concept": {
        "name": "(+)-artemisinin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "19623a61192d79c3febc05050def2b35"
    },
    {
      "bel": "a(CHEBI:\"1,8-cineole\")",
      "concept": {
        "name": "1,8-cineole",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1f4d7ef3d919cc3ab0101c9fed340dd8"
    },
    {
      "bel": "a(CHEBI:\"N(5)-ethyl-L-glutamine\")",
      "concept": {
        "name": "N(5)-ethyl-L-glutamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "171fd35330e4639f904762fe9f9666de"
    },
    {
      "bel": "a(CHEBI:\"alpha-tocopherol\")",
      "concept": {
        "name": "alpha-tocopherol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3b97d036ad2ec8eb617db903971d5fee"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "concept": {
        "name": "amyloid-beta polypeptide 42",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ef705fbb8d4e7ba18fb04daf5d329b6b"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"gallic acid\")",
      "concept": {
        "name": "gallic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f12ef3c008ad999c4fd6be9a2ee881af"
    },
    {
      "bel": "a(CHEBI:\"methyl 3,5-di-O-caffeoyl quinate\")",
      "concept": {
        "name": "methyl 3,5-di-O-caffeoyl quinate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a9475cef3d22b440cbf5de5733c89cd1"
    },
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "concept": {
        "name": "nitric oxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin E2\")",
      "concept": {
        "name": "prostaglandin E2",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c922120bcd2818906c2b9ad999a10bbc"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:\"vitamin D\")",
      "concept": {
        "name": "vitamin D",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "fd208ca9f82e3458fe111072206d4e83"
    },
    {
      "bel": "a(CHEBI:Anatabine)",
      "concept": {
        "name": "Anatabine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e5ab9569cca155e199162d8c20415b4"
    },
    {
      "bel": "a(CHEBI:Geniposide)",
      "concept": {
        "name": "Geniposide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "18746a66c22ccc2839338763d2b58fc5"
    },
    {
      "bel": "a(CHEBI:Salidroside)",
      "concept": {
        "name": "Salidroside",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "613839f733d8cfac908298bb22e91cc3"
    },
    {
      "bel": "a(CHEBI:acetylcholine)",
      "concept": {
        "name": "acetylcholine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
    },
    {
      "bel": "a(CHEBI:berberine)",
      "concept": {
        "name": "berberine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e000a97171f6295d383e673e35cee0bd"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "concept": {
        "name": "curcumin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7af57558091f98bed6718820d043f953"
    },
    {
      "bel": "a(CHEBI:galanthamine)",
      "concept": {
        "name": "galanthamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e801888eadb6e8f7cdcbdafe3172ef65"
    },
    {
      "bel": "a(CHEBI:genistein)",
      "concept": {
        "name": "genistein",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "53639bd1ad118846e01e79ec7bf1efd7"
    },
    {
      "bel": "a(CHEBI:lycopene)",
      "concept": {
        "name": "lycopene",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "d39b160930e4a88a1b83612941eb9349"
    },
    {
      "bel": "a(CHEBI:nitrotyrosine)",
      "concept": {
        "name": "nitrotyrosine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b0f7917f34f58f407238a5b50f85c720"
    },
    {
      "bel": "a(CHEBI:oridonin)",
      "concept": {
        "name": "oridonin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a8e7cf9ed82390765c7774771c3e92e7"
    },
    {
      "bel": "a(CHEBI:pterostilbene)",
      "concept": {
        "name": "pterostilbene",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a195266ad5ef5d531c03ec22ee9e961a"
    },
    {
      "bel": "a(CHEBI:resveratrol)",
      "concept": {
        "name": "resveratrol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "5f135e6a5a23eff63c77c8580afe8114"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(MESH:\"Cholinergic Agents\")",
      "concept": {
        "name": "Cholinergic Agents",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "dbdbe33602e4dff08f9719ea6382f2a0"
    },
    {
      "bel": "a(MESH:\"Nissl Bodies\")",
      "concept": {
        "name": "Nissl Bodies",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9a03c3ba875eba7b6ff1667fa6ef2adf"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Interleukins)",
      "concept": {
        "name": "Interleukins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "745669641b540755db3c10c953490eaf"
    },
    {
      "bel": "a(MESH:Neurotoxins)",
      "concept": {
        "name": "Neurotoxins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "3ef149871e4348e0397e85839cd3c807"
    },
    {
      "bel": "a(PUBCHEM:102336202)",
      "concept": {
        "name": "102336202",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "a6f4b9101faf9edce8ea286b9da8b886"
    },
    {
      "bel": "a(PUBCHEM:14193399)",
      "concept": {
        "name": "14193399",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "1c5e309b2e6d32d49648b57fd56e1837"
    },
    {
      "bel": "a(PUBCHEM:155160)",
      "concept": {
        "name": "155160",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "74c6ebd6abb36493dfdf62b86aab99b3"
    },
    {
      "bel": "a(PUBCHEM:164676)",
      "concept": {
        "name": "164676",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "54e1159e30757ddf5d638b1fd2fa6648"
    },
    {
      "bel": "a(PUBCHEM:24721561)",
      "concept": {
        "name": "24721561",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "df12167c1239e095fc176dcc09fb62d9"
    },
    {
      "bel": "a(PUBCHEM:3086007)",
      "concept": {
        "name": "3086007",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "61a9448f3e2d886769d7c33eadc46331"
    },
    {
      "bel": "a(PUBCHEM:440312)",
      "concept": {
        "name": "440312",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "a4660e6628cbc0ab426ac9251e997e8f"
    },
    {
      "bel": "a(PUBCHEM:441921)",
      "concept": {
        "name": "441921",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "c3beac0ba3c4e4f566d389ed02b24eab"
    },
    {
      "bel": "a(PUBCHEM:441923)",
      "concept": {
        "name": "441923",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "aaa7dc40e8283fb6373021b88458d765"
    },
    {
      "bel": "a(PUBCHEM:442534)",
      "concept": {
        "name": "442534",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "eafdc98ec16f45d62d028c9e45632d46"
    },
    {
      "bel": "a(PUBCHEM:444795)",
      "concept": {
        "name": "444795",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "82312fe78f73d22d99a869ccee132665"
    },
    {
      "bel": "a(PUBCHEM:44584733)",
      "concept": {
        "name": "44584733",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0ae4d21ad7caae343900957d59d0ea48"
    },
    {
      "bel": "a(PUBCHEM:45270574)",
      "concept": {
        "name": "45270574",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "645bc629911ca02bc370743f0a18c3ea"
    },
    {
      "bel": "a(PUBCHEM:73078)",
      "concept": {
        "name": "73078",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0f8d5cec18d9e7feb097cd12a370c1c1"
    },
    {
      "bel": "a(PUBCHEM:9918693)",
      "concept": {
        "name": "9918693",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "33b5ecbf9ece0320e37b4c1254f9f159"
    },
    {
      "bel": "bp(GO:\"NIK/NF-kappaB signaling\")",
      "concept": {
        "name": "NIK/NF-kappaB signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "17366975eb5fd98b20a8228a5e1479bd"
    },
    {
      "bel": "bp(GO:\"NLRP3 inflammasome complex assembly\")",
      "concept": {
        "name": "NLRP3 inflammasome complex assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9533ce1c66aff93c324c8cb79434f218"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "concept": {
        "name": "apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9eb8739869ef0e82697f61a33d3d6afa"
    },
    {
      "bel": "bp(GO:\"glial cell activation\")",
      "concept": {
        "name": "glial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4d32d1d54cdea811eb45d1daa3d71a5a"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:learning)",
      "concept": {
        "name": "learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "75fc4f4e732353b87f83a4a8174ffb29"
    },
    {
      "bel": "bp(GO:memory)",
      "concept": {
        "name": "memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e03a718b44a1ff30acea5c31966879a9"
    },
    {
      "bel": "complex(a(CHEBI:galanthamine), p(FPLX:CHRN))",
      "function": "Complex",
      "id": "1b3c90fbb057c023b6ae2e55ceefaa0a",
      "members": [
        {
          "bel": "a(CHEBI:galanthamine)",
          "concept": {
            "name": "galanthamine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "e801888eadb6e8f7cdcbdafe3172ef65"
        },
        {
          "bel": "p(FPLX:CHRN)",
          "concept": {
            "name": "CHRN",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "83ec6f28701674367e6d6be212520d7d"
        }
      ]
    },
    {
      "bel": "complex(g(HGNC:BACE1), p(FPLX:NFkappaB))",
      "function": "Complex",
      "id": "ebdaf9dba23507b3f5dc8cb053705ecf",
      "members": [
        {
          "bel": "g(HGNC:BACE1)",
          "concept": {
            "name": "BACE1",
            "namespace": "HGNC"
          },
          "function": "Gene",
          "id": "901e62c3177c512bb5513822d159cea5"
        },
        {
          "bel": "p(FPLX:NFkappaB)",
          "concept": {
            "name": "NFkappaB",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "dafcbe06460fc2e93f4daf2113f37665"
        }
      ]
    },
    {
      "bel": "g(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "901e62c3177c512bb5513822d159cea5"
    },
    {
      "bel": "p(FPLX:\"Gamma_secretase\")",
      "concept": {
        "name": "Gamma_secretase",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e5aa42b4d5a7992fe30ecc5d01ae8dd8"
    },
    {
      "bel": "p(FPLX:\"IKK_complex\")",
      "concept": {
        "name": "IKK_complex",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "29511753c451400e5272d42ec5f9dc64"
    },
    {
      "bel": "p(FPLX:\"IKK_complex\", pmod(Ph))",
      "concept": {
        "name": "IKK_complex",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "5e6af365ca153e7010a4adcd033aab95",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:\"NADPH_oxidase\")",
      "concept": {
        "name": "NADPH_oxidase",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "7cd3e03060c31b50361c64dbb68cb5b2"
    },
    {
      "bel": "p(FPLX:AKT)",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
    },
    {
      "bel": "p(FPLX:CHRN)",
      "concept": {
        "name": "CHRN",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "83ec6f28701674367e6d6be212520d7d"
    },
    {
      "bel": "p(FPLX:ERK)",
      "concept": {
        "name": "ERK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "0dc4dd8e21abefb97f64a360af4aeb2b"
    },
    {
      "bel": "p(FPLX:ERK, pmod(Ph))",
      "concept": {
        "name": "ERK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "a43814cda6b7f20abb3c9e3d5f7d0096",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:GSK3)",
      "concept": {
        "name": "GSK3",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "7c97ba981a90ae260bb5f21c9f0ce7c9"
    },
    {
      "bel": "p(FPLX:IKB)",
      "concept": {
        "name": "IKB",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "9924439209fe2342bab1d26215d2636a"
    },
    {
      "bel": "p(FPLX:JNK)",
      "concept": {
        "name": "JNK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "652ceb8427d17b6e5e19d76428838c42"
    },
    {
      "bel": "p(FPLX:JNK, pmod(Ph))",
      "concept": {
        "name": "JNK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "5e3485722c3530db9992e8351c158687",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:MYST)",
      "concept": {
        "name": "MYST",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "a111fe8e4a9dbb49e8573233271b5f6c"
    },
    {
      "bel": "p(FPLX:NFkappaB)",
      "concept": {
        "name": "NFkappaB",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "dafcbe06460fc2e93f4daf2113f37665"
    },
    {
      "bel": "p(FPLX:NFkappaB, pmod(Ph))",
      "concept": {
        "name": "NFkappaB",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "661a905af3a082c48f23846479fabe60",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:PKC)",
      "concept": {
        "name": "PKC",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "87ce0784f471e52c33e62487ca260549"
    },
    {
      "bel": "p(FPLX:SOD)",
      "concept": {
        "name": "SOD",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "3bfefd821054c2ab3a8f883296464c85"
    },
    {
      "bel": "p(HGNC:ACHE)",
      "concept": {
        "name": "ACHE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d4b209d60c245bf738c274ea16eaac1b"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:CHUK)",
      "concept": {
        "name": "CHUK",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9c1fa58e8fe80330403e1557850d9f53"
    },
    {
      "bel": "p(HGNC:CXCL8)",
      "concept": {
        "name": "CXCL8",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "325a76cdc17ef7ce6a715ed6201f2a09"
    },
    {
      "bel": "p(HGNC:GFAP)",
      "concept": {
        "name": "GFAP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "15da8945521071a11aee0c5e255276f4"
    },
    {
      "bel": "p(HGNC:HMOX1)",
      "concept": {
        "name": "HMOX1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d8af6078f1872edbf59623df2a9fa1c2"
    },
    {
      "bel": "p(HGNC:IKBKB)",
      "concept": {
        "name": "IKBKB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5dc945f5997da1736276b351fed21de6"
    },
    {
      "bel": "p(HGNC:IL12B)",
      "concept": {
        "name": "IL12B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "60dbcf5bfd39cff30cca20dce8691ea4"
    },
    {
      "bel": "p(HGNC:IL1A)",
      "concept": {
        "name": "IL1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "017f14e3a15a95b856bdaba5630dcf34"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cca08112d9fcf1a31015f1dbfc30b04c"
    },
    {
      "bel": "p(HGNC:IL2)",
      "concept": {
        "name": "IL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "99fcd5fe54813ead0bd02d8a06f42173"
    },
    {
      "bel": "p(HGNC:IL6)",
      "concept": {
        "name": "IL6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8a1d3c4828c5416eba867c395cc65caa"
    },
    {
      "bel": "p(HGNC:LOX)",
      "concept": {
        "name": "LOX",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3db89071a3d0e3670f69126d552e0912"
    },
    {
      "bel": "p(HGNC:MAPK14)",
      "concept": {
        "name": "MAPK14",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0c0476ae2f3918834fb6ae31829c9b8d"
    },
    {
      "bel": "p(HGNC:MAPK14, pmod(Ph))",
      "concept": {
        "name": "MAPK14",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fc83ba5f82d0f639ed93cf32b50f13e9",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MMP2)",
      "concept": {
        "name": "MMP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "78511410fc96842c39ecd264fc2ea9e0"
    },
    {
      "bel": "p(HGNC:NFKBIA)",
      "concept": {
        "name": "NFKBIA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "28d32c6c98451e7b39d3e27ade59cb9a"
    },
    {
      "bel": "p(HGNC:NFKBIA, pmod(Ph))",
      "concept": {
        "name": "NFKBIA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "af7690d961cf7db7832a8d307c1337ff",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:NOS2)",
      "concept": {
        "name": "NOS2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "65765ae76206b40d993591e8b138acd4"
    },
    {
      "bel": "p(HGNC:PPARA)",
      "concept": {
        "name": "PPARA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e79d7558c9c95c0b46af286735dc815f"
    },
    {
      "bel": "p(HGNC:PTGS2)",
      "concept": {
        "name": "PTGS2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fcfa5df7382bf321071715cd08501263"
    },
    {
      "bel": "p(HGNC:RELA)",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "64cb49613db164980ff43274b6c270cf"
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ac))",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bf712dcdd8972ddd912e2c0418097eab",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ph))",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cf5af122438c46b3b2db16bb924ef9ed",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:STAT1)",
      "concept": {
        "name": "STAT1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4406636e0faeaf0a1fb400403144d48b"
    },
    {
      "bel": "p(HGNC:STAT1, pmod(Ph))",
      "concept": {
        "name": "STAT1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "82d978dd82b68bbd7ea4f731c519de53",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:STAT3)",
      "concept": {
        "name": "STAT3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9523cd88bdb7daf4a0aaf38eb43fbe28"
    },
    {
      "bel": "p(HGNC:STAT3, pmod(Ph))",
      "concept": {
        "name": "STAT3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b459f1fb99346abf4c46d7a952b1cc1f",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:TLR3)",
      "concept": {
        "name": "TLR3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8e283e8a56191737442a695574bbee2b"
    },
    {
      "bel": "p(HGNC:TLR4)",
      "concept": {
        "name": "TLR4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4d3aa2ce51d0cd7f2aa9267a9c61f9f7"
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(HGNC:TRAF6)",
      "concept": {
        "name": "TRAF6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c8dbe00612e3bf1cb55f201df44f953a"
    },
    {
      "bel": "p(HGNC:TXN)",
      "concept": {
        "name": "TXN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fe56c5ac812f2cbe5bc16e43c84a87c4"
    },
    {
      "bel": "p(HGNC:TXNIP)",
      "concept": {
        "name": "TXNIP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7ebac14088843bc35544556c61553057"
    },
    {
      "bel": "path(HP:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "ff6883c524d877c644e0ba4e8f3323aa"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Neurotoxicity Syndromes\")",
      "concept": {
        "name": "Neurotoxicity Syndromes",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "74054e2d9d497286c20c13bc68742e6c"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5d5071d9dea362c9b9b6ee5de9eb67be"
    },
    {
      "bel": "path(MESH:\"Spatial Learning\")",
      "concept": {
        "name": "Spatial Learning",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4df0a710dfcb6be8ee0e83a75e30d3a9"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "concept": {
        "name": "Spatial Memory",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6689b53b9c19fb722f9715d6f4df2ecc"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "r(FPLX:IKB)",
      "concept": {
        "name": "IKB",
        "namespace": "FPLX"
      },
      "function": "RNA",
      "id": "6ade99d979520c5b9647d7b55e8a25a1"
    },
    {
      "bel": "r(FPLX:NFkappaB)",
      "concept": {
        "name": "NFkappaB",
        "namespace": "FPLX"
      },
      "function": "RNA",
      "id": "ffe75227878306a8ba971074ef49c631"
    },
    {
      "bel": "r(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "757c37fa1fc6c44e204bc61d5104c60f"
    },
    {
      "bel": "r(HGNC:IFNB1)",
      "concept": {
        "name": "IFNB1",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "0741df84ff6642ebb4c57401b4765a09"
    },
    {
      "bel": "r(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "5fa99a5398e196b8c3ed2fe80e8fc32a"
    },
    {
      "bel": "r(HGNC:IL4)",
      "concept": {
        "name": "IL4",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "0dfce71b99645a28ecde43ffc0cbaf64"
    },
    {
      "bel": "r(HGNC:IL6)",
      "concept": {
        "name": "IL6",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "5080f7e156b0d46f95fe8defa45ce659"
    },
    {
      "bel": "r(HGNC:NLRP3)",
      "concept": {
        "name": "NLRP3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "71c9cb38378a8aa887e68724d5f1f48e"
    },
    {
      "bel": "r(HGNC:NOS2)",
      "concept": {
        "name": "NOS2",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "a326cfb47831068f0627c574a856fef3"
    },
    {
      "bel": "r(HGNC:PTGS2)",
      "concept": {
        "name": "PTGS2",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "c940b2c15cc8426b2826c4c503669562"
    },
    {
      "bel": "r(HGNC:RBFOX3)",
      "concept": {
        "name": "RBFOX3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "edb761682b050b26eb31ead9291470ab"
    },
    {
      "bel": "r(HGNC:RELA)",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "05205967b4df54e9d28deb8a88dfa10e"
    },
    {
      "bel": "r(HGNC:TLR3)",
      "concept": {
        "name": "TLR3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "1c9f59459f0987ceda287cca4db7710c"
    },
    {
      "bel": "r(HGNC:TLR4)",
      "concept": {
        "name": "TLR4",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "dc03041833c7fb6cb74660a23d41f5d1"
    },
    {
      "bel": "r(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "c7cb5c65848a9c337fa0e8b87d7110d4"
    },
    {
      "bel": "r(HGNC:TRAF6)",
      "concept": {
        "name": "TRAF6",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "78d9a4e567a5ea676bf4b43c859eef67"
    }
  ]
}